Cargando…
CRISPR/Cas9-Mediated Knockin Application in Cell Therapy: A Non-viral Procedure for Bystander Treatment of Glioma in Mice
The use of non-viral procedures, together with CRISPR/Cas9 genome-editing technology, allows the insertion of single-copy therapeutic genes at pre-determined genomic sites, overcoming safety limitations resulting from random gene insertions of viral vectors with potential for genome damage. In this...
Autores principales: | Meca-Cortés, Oscar, Guerra-Rebollo, Marta, Garrido, Cristina, Borrós, Salvador, Rubio, Nuria, Blanco, Jeronimo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5537198/ https://www.ncbi.nlm.nih.gov/pubmed/28918039 http://dx.doi.org/10.1016/j.omtn.2017.07.012 |
Ejemplares similares
-
Targeting of replicating CD133 and OCT4/SOX2 expressing glioma stem cells selects a cell population that reinitiates tumors upon release of therapeutic pressure
por: Guerra-Rebollo, Marta, et al.
Publicado: (2019) -
Glioblastoma Bystander Cell Therapy: Improvements in Treatment and Insights into the Therapy Mechanisms
por: Guerra-Rebollo, Marta, et al.
Publicado: (2018) -
Application of an assay Cascade methodology for a deep preclinical characterization of polymeric nanoparticles as a treatment for gliomas
por: Fornaguera, Cristina, et al.
Publicado: (2018) -
Exome sequencing in the knockin mice generated using the CRISPR/Cas system
por: Nakajima, Kazuo, et al.
Publicado: (2016) -
CRISPR/Cas9-mediated gene knockin in the hydroid Hydractinia symbiolongicarpus
por: Sanders, Steven M., et al.
Publicado: (2018)